|
|
|
RESEARCH PAPER
1 Department of Molecular Genetics, University of Texas, The M.D. Anderson Cancer Center, Houston, Texas 77030, USA; 2 Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado 80523, USA; 3 Centre de Recherche en Cancérologie de l'Université Laval, Hôpital Hôtel-Dieu de Québec, Québec, Canada G1R 2J6; 4 Department of Medical Oncology and Center for Applied Cancer Science, Dana-Farber Cancer Institute and Departments of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA
| Abstract |
|---|
|
|
|---|
[Keywords: Werner; alternative lengthening of telomeres; cancer; escape from senescence; telomeres]
Received April 5, 2005; revised version accepted September 6, 2005.
Increasing evidence supports the hypothesis that WRN plays a direct role in telomere maintenance. Telomeres are specialized nucleoprotein structures consisting of G-rich repetitive sequences that cap the ends of eukaryotic chromosomes and are crucial for the maintenance of chromosomal stability (for review, see Smogorzewska and de Lange 2004
). Telomeres are maintained by the enzyme telomerase, which consists of an essential telomerase RNA (Terc) that serves as a template for the addition of telomere repeats, and a protein component, the telomerase reverse transcriptase catalytic subunit (Tert). Accelerated loss of telomere reserves and activation of cellular checkpoints appear integral to the decreased replicative potential observed in WS, as evidenced by the capacity of enforced TERT expression to impart unlimited replicative potential (Wyllie et al. 2000
). However, it is possible that TERT overexpression may activate additional proliferative pathways other than those linked to telomere maintenance (Blasco 2002
).
A central role of dysfunctional telomeres in driving the WS phenotypes has received genetic support from mice doubly deficient for telomerase and WRN. In this model, while Wrn deficiency alone had no cellular or tissue phenotypes (Lombard et al. 2000
), successive generational matings of mTerc-/- Wrn+/- mice and ensuing telomere dysfunction produced symptoms and pathologies with striking similarities to the human disease, including a full spectrum of premature aging phenotypes and elevated incidence of mesenchymal cancers (S. Chang et al. 2004
; Du et al. 2004
). On the cellular level, late-generation mTerc-/- Wrn-/- mouse embryo fibroblasts (MEFs) exhibited profound premature replicative senescence similar to that seen in human WS fibroblasts (S. Chang et al. 2004
; Du et al. 2004
). These murine observations, together with those derived from the study of human WS cells, strongly support the hypothesis that the WRN deficiency exerts its complex and diverse pathophysiological consequences primarily through accelerated telomere erosion and associated dysfunction.
WRN functionally interacts with a number of proteins involved in telomere length maintenance, indicating that it may influence telomerase access to the 3' G-rich overhang by unwinding the t-loop structure adopted by mammalian telomeres (Opresko et al. 2004
). WRN also localizes to telomeres of telomerase-deficient cells that maintain telomeres via the alternative lengthening of telomeres (ALT) mechanism (Johnson et al. 2001
; Opresko et al. 2004
). In addition, WRN is required for the efficient replication of lagging strand telomeric DNA, suggesting that WRN may function during telomere replication by resolving aberrant DNA structures that block replication forks (Crabbe et al. 2004
).
In this study, we utilized genetically defined mouse cells to understand the impact of WRN deficiency on telomere maintenance, chromosomal stability, cellular mortality, and tumorigenesis. Our results indicate that the increased incidence of chromosomal instability and cancer in WS may be due to aberrant recombinations between sister chromatids specifically at telomeres, which may promote the activation of the ALT pathway and lead to chromosomal instability during tumorigenesis.
| Results |
|---|
|
|
|---|
The profound senescence phenotype exhibited by G5 mTerc-/- Wrn-/- MEFs prevented the generation of immortalized cell lines via the standard 3T3 protocol, whereas generation 3 (G3) mTerc-/- Wrn-/- and wild-type MEFs with adequate telomere reserves readily generated immortalized 3T3 cultures (S. Chang et al. 2004
). To further assess the immortalization potential of late-generation mTerc-/- Wrn-/- cells, we adopted an alternative approach that monitored spontaneous focus formation in senescent MEF cultures maintained by weekly media changes. After
2 mo in culture, several foci emerged among 8 x 106 senescent G5 mTerc-/- Wrn-/- MEFs at a frequency of
1.4 x 10-5.
Under identical culture conditions, foci were not detected in senescent cultures of
5 x 107 G5 mTerc-/- Wrn+/+ and
2.5 x 107 G5 mTerc-/- Wrn+/- MEFs. To assess the growth properties of these cells, six independently derived foci originating from five different G5 mTerc-/- Wrn-/- embryos were subcloned, expanded, and subjected to serial passages (Fig. 1A). All clones displayed robust growth curves over 100 population doublings (PDs), characteristic of immortalized cells. These observations suggest that Wrn deficiency can facilitate escape from senescence and are permissive for the sustained growth of mTerc-/- cultures with significant telomere dysfunction.
To gain insight into the molecular basis of immortalization, we assayed the integrity of the p19Arf-p53 pathway in early passage and immortal G5 mTerc-/- Wrn-/- cultures. Inactivation of this pathway is an obligate event in the immortalization of murine cells (for review, see Ben-Porath and Weinberg 2004
). Although early passage cultures revealed the typical low p53 levels (Liu et al. 2004
), the functional integrity of p53 is evidenced by ionizing radiation (IR)-induced induction of the p53-responsive target, p21. In contrast, all six independently derived G5 mTerc-/- Wrn-/- immortal cultures showed moderate p53 expression yet failed to exhibit IR-induced p21 induction. In addition, these immortal cultures expressed high p19Arf levels (Fig. 1B), the latter consistent with loss of p53 feedback inhibition (Quelle et al. 1995
; Kamijo et al. 1997
). These results indicate that G5 mTerc-/- Wrn-/- cell lines experienced disruption of the p19Arf-p53 axis upon immortalization.
Telomere status and formation of telomere double minute chromosomes in immortalized G5 mTerc-/- Wrn-/- clones
The critical roles of telomeres and the WRN helicase in the maintenance of genome integrity (S. Chang et al. 2004
) and the reported increasing chromosomal instability in human cultures emerging from telomere-based replicative senescence (Counter et al. 1992
; Romanov et al. 2001
) prompted a detailed cytogenetic analysis of parental and immortal cultures. In contrast to the paucity of chromosomal aberrations in early passage parental cultures, all six immortalized G5 mTerc-/- Wrn-/- cell lines displayed numerous chromosomal aberrations typified by homologous p-p arm (Robertsonian-like) fusions, unstable q-q arm fusions (generating dicentric chromosomes), and chromatid breaks (Fig. 1C). Spectral karyotyping (SKY) revealed multiple nonreciprocal translocations (NRTs) (Fig. 1D). Consistent with the ability of dicentric chromosomes to generate unstable anaphase bridges (for review, see Maser and DePinho 2002
), anaphase bridges were detected in all immortalized cell lines but were not evident in respective parental cultures (Fig. 2A,B; data not shown). In line with these observed chromosome breakage events,
H2AX signal was readily detected in the immortal G5 mTerc-/- Wrn-/- cell lines and formed characteristic DNA damage-induced foci (Fig. 1B; data not shown). Together, these patterns prompt speculation that randomly broken anaphase bridges generate highly recombinogenic chromosomal intermediates that give rise to the complex cytogenetic profiles of the immortalized G5 mTerc-/- Wrn-/- cell lines.
|
|
0.9 per metaphase (Fig. 2C). Theses structures resemble double minute chromosomes (DMs), circular DNA elements that are frequently observed in genomically unstable cell lines undergoing drug selection. The DMs in our immortalized cell lines contained two telomeric signals that were of similar intensity to telomeres at the ends of chromosomes and bear striking resemblance to recently described telomeric DNA-containing DMs (TDMs), proposed to result from aberrant recombination events between telomeric sequences and chromosome-internal telomeric repeats (Zhu et al. 2003
Telomere sister chromatid exchange (T-SCE) is elevated in G5 mTerc-/- Wrn-/- cells
To assess whether telomeric recombination is elevated in immortalized G5 mTerc-/- Wrn-/- clones, we utilized chromosome orientation (CO)-FISH to assess the frequency of T-SCEs (Bailey et al. 2004
). CO-FISH typically yields a characteristic pattern of two telomere signals, one on each end of the chromosome marking either lagging or leading strands, depending on the probe used for hybridization (Bailey et al. 2001
). However, a T-SCE event within telomeric DNA splits the probe hybridization signal between the sister chromatids, creating a three-telomere (or four-telomere) hybridization pattern of signals that are often of unequal intensity (Fig. 3A). T-SCEs were rare in mTerc+/+ Wrn+/- and parental G5 mTerc-/- Wrn+/- MEF controls (Fig. 3B,D). G3 mTerc-/- Wrn-/- MEFs exhibited a twofold increase in the number of T-SCEs over controls, indicating that loss of WRN function may induce a low level of T-SCE in the setting of largely functional telomeres (Fig. 3D). Particularly noteworthy is the observation of a sixfold average increase in T-SCE levels in G5 mTerc-/- Wrn-/- parental cells (Fig. 3C,D, p < 0.05), indicating a dual requirement for Wrn deficiency and telomere dysfunction in driving dramatically elevated T-SCE levels. These T-SCE rates remained elevated in all immortalized cell lines examined (Fig. 3D). Elevated recombination was specific to telomeric DNAs in G5 mTerc-/- Wrn-/- cells, as evidenced by background levels of SCEs not only in genomic DNA (Fig. 3E), but also in the mouse major satellite, highly repetitive blocks of pericentromeric repeat DNA (Fig. 3F). These results suggest that WRN normally functions to repress recombination specifically within telomeric DNA.
|
Suppression of T-SCEs requires WRN helicase activity
To further investigate the involvement of WRN in modulating T-SCE levels, we expressed cDNAs encoding wild-type human or mouse WRN in G5 mTerc-/- Wrn-/- parental and immortalized cell lines (Fig. 4A,E). In contrast to vector-infected controls, reconstitution with either human or mouse WRN enabled early passage G5 mTerc-/- Wrn-/- MEFs to bypass premature replicative senescence and extended cellular lifespan by an additional 10 PDs (Fig. 4B). Importantly, sister telomere loss (STL), a characteristic of WS cells proposed to be due to an inability to efficiently replicate lagging strand telomeric DNA (Crabbe et al. 2004
), was significantly reduced in WRN, but not in vector-reconstituted G5 mTerc-/- Wrn-/- cells (Fig. 4C, p < 0.001). In addition, the elevated number of DNA damage foci observed in G5 mTerc-/- Wrn-/- MEFs (S. Chang et al. 2004
) was reduced threefold in wild-type WRN, but not vector-reconstituted cell lines (data not shown). Taken together, these data show that reconstitution of WRN activity efficiently rescued many of the telomere-associated defects observed in G5 mTerc-/- Wrn-/- cells. Correspondingly, compared with two vector-transfected control cells, T-SCEs were reduced by 50%-70% (p < 0.001) in two WRN reconstituted G5 mTerc-/- Wrn-/- parental and immortalized cell lines (Fig. 4D,F,G), consistent with the view that suppression of T-SCEs requires functional WRN activity. Interestingly, reconstitution of telomerase activity in two independent G5 mTerc-/- Wrn-/- immortalized clones did not significantly alter the levels of T-SCE, suggesting that once T-SCE is engaged, it is not shut down by active telomerase (Fig. 4D).
|
G5 mTerc-/- Wrn-/- cell lines are tumorigenic and engage the ALT pathway in vivo
The known cancer-prone condition of WS patients and mTerc-/- Wrn-/- mice prompted us to determine the cancer implications of the enhanced immortalization potential and chromosomal instability observed in immortal G5 mTerc-/- Wrn-/- cell lines. In contrast to 0/16 tumors formed when parental G5 mTerc-/- Wrn-/- cells were injected subcutaneously into SCID mice, subcutaneous injection of 10/22 H-RasV12 transfected, immortalized G5 mTerc-/- Wrn-/- clones (with loss of p53 function) into SCID mice generated highly malignant tumors (median latency 3.5 wk) (Fig. 5A, p < 0.01; Table 1; Supplementary Fig. S2). Notably, 24/32 subcutaneous injections of vector-transfected, immortalized G5 mTerc-/- Wrn-/- clones also yielded aggressive tumors, but with a longer median latency of
6.3 wk (Fig. 5A; Table 1, p < 0.004). In contrast, injections of 12 spontaneously immortalized early passage G5 mTerc-/- Wrn+/+ p53-/- MEFs did not produce any tumors in SCID mice within 20 wk (Table 1). This result suggests that, in the setting of telomere dysfunction, p53 loss can cooperate with Wrn deficiency to promote tumorigenesis. However, it is also possible that the enhanced genomic instability observed in immortalized G5 mTerc-/- Wrn-/- clones produced additional oncogenic insults that may help promote tumorigenesis. Histological analysis of both SCID tumor types revealed that they were well-differentiated sarcomas (hence designated V-sarcoma and H-RasV12-sarcoma) (Fig. 5B). Cytogenetic analysis revealed that both sarcomas possessed an increased number of chromosome fusions over injected parental cell lines (fourfold for V-sarcoma and sixfold for H-RasV12-sarcoma), documenting elevated genomic instability in these tumors (Fig. 5C). Quantitative telomere FISH (Q-FISH) analysis revealed a significant decrease in average telomere lengths in both tumor types compared with parental controls (60% for V-sarcoma, 45% for H-RasV12-sarcoma [p < 0.05 for both]) (Fig. 5D). While a fourfold to 6.8-fold increase in the number of telomere signal-free chromosome ends was detected in metaphase spreads from V-sarcomas and H-RasV12-sarcomas, a number of chromosomes with telomeres 5.3x to 8.5x longer than average was also observed (Fig. 5C,D). Analysis of telomere lengths by TRF Southern revealed that, in contrast to parental and injected immortalized cell lines, both V-sarcomas and H-RasV12-sarcomas displayed a TRF pattern characteristic of human and mouse ALT cells (Fig. 6A; Yeager et al. 1999
; Chang et al. 2003
). In particular, telomere lengths were heterogeneous, ranging from
100 to 8 kb in length. Size heterogeneity was also observed in the 3' overhangs of the ALT cells (Fig. 6A). Elevated numbers of anaphase bridges, TDMs, and T-SCEs were found in both tumors, suggesting ongoing telomeric recombination (Figs. 2B,C, 3D).
|
|
5%-6% of two independently derived ALT V-sarcoma lines examined showed colocalization of TRF1 with PML in brightly staining large nuclear structures resembling APBs (Fig. 6B,C). This colocalization was not observed in parental and immortalized cell lines (Fig. 6B,C; data not shown). Reconstitution of telomerase activity in two independently derived ALT V-sarcoma cell lines did not reduce the number of APBs observed (Fig. 6C) nor did it affect the growth rates of these cells in vitro (data not shown). Taken together, these results suggest that under the biological pressure of tumorigenesis in vivo, the ALT pathway was activated in immortalized G5 mTerc-/- Wrn-/- clones in order to allow for subcutaneous tumor growth in SCID mice. | Discussion |
|---|
|
|
|---|
|
3 wk for H-Ras-transfected and
6 wk for vector-transfected G5 mTerc-/- Wrn-/- cell lines favors the view that repair of dysfunctional telomeres by the ALT mechanism, and not the de novo acquisition of rare mutations, is the major contributor of tumor progression in vivo. We surmise that additional factors involved in modulating the ALT pathway are required for tumorigenesis. The telomerase-Werner compound knockout mouse thus offers a unique platform to discover novel genes involved in ALT activation during tumor formation. T-SCE levels in ALT tumor cell lines was not repressed when telomerase was expressed in these cells, consistent with previous observations indicating that once ALT is activated, it is not normally repressible by telomerase expression (Cerone et al. 2001
The finding that human ALT cell lines also display elevated T-SCEs (Bechter et al. 2004
; Londono-Vallejo et al. 2004
) suggests that aberrant homologous recombination (HR) at telomeres may be important for telomere length maintenance in these cells (Dunham et al. 2000
). Recent observations that human ALT cells possess extrachromosomal telomere circles, most likely generated through HR (Cesare and Griffith 2004
; Wang et al. 2004
), and require the HR protein RAD51D for proper telomere maintenance (Tarsounas et al. 2004
) further support this hypothesis. Our observation that TDMs and T-SCEs were prominent in immortalized G5 mTerc-/- Wrn-/- cell lines suggests that acquisition of HR-mediated telomere recombination mechanisms may be an important prerequisite for transition to the ALT phenotype. TDMs are postulated to be the product of aberrant homologous recombination events between telomeres and chromosomal internal TTAGGG repeats sequences (Zhu et al. 2003
), and our data suggest that WRN normally inhibits this activity. While the mechanism underlying T-SCEs has not been identified, our results suggest that lost of WRN function may be important for the initiation of aberrant/deregulated recombinations at telomeres. We have previously demonstrated that T-SCE is a reciprocal event; i.e., the G-rich and C-rich telomere probes produce reciprocal CO-FISH patterns (Bailey et al. 2004
). So, although SCE is generally believed to be a recombinational event, it is not typical in the general sense of commonly described models. One widely accepted aspect of SCE, however, is that it is associated with passage of the replication fork. T-SCEs may be triggered when a replication fork encounters a block in one of the parental template strands, leading to DNA polymerase stalling. This replication block may involve in vivo formation of G-quadruplexes, intramolecular structures containing G-quartets of four hydrogen-bonded guanines, on G-rich telomeric sequences (Schaffitzel et al. 2001
; C.C. Chang et al. 2004
; Granotier et al. 2005
). WRN preferentially localizes to telomeres during the S-phase (Opresko et al. 2004
; Crabbe et al. 2004
) and can efficiently unwind G-quadruplexes in a helicase-dependent manner (Mohaghegh et al. 2001
). We postulate that WRN normally resolves G-quadruplexes during DNA replication, allowing replication fork progression and complete synthesis of telomeric DNA. Lack of WRN helicase activity leads to replication fork stalling, resulting in loss of the lagging strand telomeric DNA (Crabbe et al. 2004
) and elevated exchanges among sister telomeres. Along these lines, it is interesting to note the recently reported physical association between WRN and the single-stranded telomere-binding protein Pot1 (Opresko et al. 2005
). Pot1 cooperates with WRN to efficiently unwind telomeric substrates, and Pot1 can also disrupt G-quadruplexes, allowing telomerase to efficiently extend even these unfavorable substrates in vitro (Zaug et al. 2005
). It is possible that both WRN and Pot1 cooperate to dissociate G-quadruplexes to facilitate telomere replication.
In summary, our results suggest that an increased propensity to escape cellular senescence due to elevated recombinations between sister telomeres may underlie the increased cancer incidence observed in WS patients. T-SCEs may also facilitate the activation of the ALT pathway to promote cancer-relevant chromosomal aberrations and engender tumor formation. It will thus be informative to determine whether aberrant telomeric recombinations and activation of the ALT mechanism are present in tumors isolated from WS patients.
| Materials and methods |
|---|
|
|
|---|
Mouse embryonic fibroblasts (MEFs) were prepared from individual day 13.5 G3 and G5 mTerc-/- Wrn-/-, Wrn+/+, and Wrn+/- embryos. Six independently derived MEF cell lines of each genotype were used in all analyses. Serial passages of cell lines were performed according to the NIH3T3 protocol as described (Blasco et al. 1997
). Cells at defined passages were harvested for chromosomal, TRF Southern, and Western analysis. TRF Southern analysis was performed as previously described (Chang et al. 2003
).
Cytogenetics, Q-FISH, and SKY analysis
Metaphase chromosomes from MEFs were prepared as described (Chang et al. 2003
) and subjected to Giemsa staining and/or FISH with Cy-3 labeled T2AG3 PNA probe. Q-FISH was performed as described (Baerlocher and Lansdorp 2004
). Images were dark subtracted and flat fielded prior to quantitative analysis. SKY was performed according to manufacturer's recommendations using mouse chromosome paint probes (Applied Spectral Imaging). Depending on the quality of metaphase spreads, 10-20 metaphases from each sample were analyzed in detail.
CO-FISH analysis
CO-FISH has been described in detail previously (Bailey et al. 2001
). Hybridization was performed with TRITC-OO-TTA GGGTTAGGGTTAGGG or FITC-OO-CCCTAACCCTAAC CCTAACCCA probes (Applied Biosystems). Fifteen to 25 metaphases/condition were scored blinded. Pairwise comparisons for statistical significance were made by Student's t-test. Differences between genetic backgrounds are considered significant only when p values were <0.05.
Immunofluoescence and Western blot analysis
Cells were subjected to IF as described (Zhu et al. 2003
). Primary antibodies used were rabbit anti-mouse TRF1 at 1:4000 (a kind gift from Dr. Jan Karlseder, Salk Institute, San Diego, CA) and mouse monoclonal anti-mouse PML at 1:500 (a kind gift from Dr. Kun Sang Chang, M.D. Anderson Cancer Center, Houston, TX). Secondary antibodies were anti-rabbit Alexa 488 and anti-mouse Alexa 595, both at 1:1000. The antibodies used for Western analyses were anti-mouse p53 (Pab 240, NeoMarkers; 1: 250), p19ARF (ab80-50, ABCAM; 1:250), p16 (M156SC, Santa Cruz; 1:200), p21 (SC-6246, Santa Cruz; 1:200), and
H2AX (AP132P, Upstate; 1:500). Anti-mouse actin (MAB1501, Chemicon; 1:20000) was used as a loading control.
Reconstitution of telomerase activity in G5 mTerc-/- Wrn-/- MEFs and TRAP assay
Immortalized cell lines were cotransfected with 20 µg of mTerc plasmid DNA and 1 µg pBabe-puro vector DNA and then selected with 4 µg/mL puromycin. Successful reconstitution was determined by telomerase activity via the TRAP assay (Oncor).
Reconstitution of telomerase activity in G5 mTerc-/- Wrn-/- MEFs
Indicated cell lines were infected with full-length human WRN, K577M-WRN, and E84A-WRN cDNAs as previously described (Crabbe et al. 2004
). Murine full-length WRN was subcloned into the pQCXIP retroviral vector (BD Biosciences) and used to infect MEF cell lines.
Transformation assay and SCID tumor injections
Early passage parental and immortalized G5 mTerc-/- Wrn-/- MEFs, and p53R172P/R172P MEFs were transfected with either pBabe vector DNA or pBabe-H-Ras as described (Liu et al. 2004
). Transformed foci were quantitated by Giemsa staining and propagated into cell lines. SCID injections were performed as previously described (Chang et al. 2003
). Tumors were monitored daily and mice sacrificed when tumors reached 1 cm in greatest dimension.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1321305.
5 These authors contributed equally to this work. ![]()
7 E-MAIL ron_depinho{at}dfci.harvard.edu; FAX (617) 632-6069. ![]()
6 E-MAIL schang{at}mdanderson.org; FAX (713) 834-6319. ![]()
| References |
|---|
|
|
|---|
Bailey, S.M., Brenneman, M.A., and Goodwin, E.H. 2004. Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res. 32: 3743-3751.
Baerlocher, G.M. and Lansdorp, P.M. 2004. Telomere length measurements using fluorescence in situ hybridization and flow cytometry. Methods Cell Biol. 75: 719-750.[Medline]
Bechter, O.E., Zou, Y., Walker, W., Wright, W.E., and Shay, J.W. 2004. Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res. 64: 3444-3451.
Ben-Porath, I. and Weinberg, R.A. 2004. When cells get stressed: An integrative view of cellular senescence. J. Clin. Invest. 113: 8-13.[CrossRef][Medline]
Bertrand, P., Rouillard, D., Boulet, A., Levalois, C., Soussi, T., and Lopez, B.S. 1997. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 14: 1117-1122.[CrossRef][Medline]
Blasco, M.A. 2002. Telomerase beyond telomeres. Nat. Rev. Cancer 2: 627-633.[CrossRef][Medline]
Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A., and Greider, C.W. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.[CrossRef][Medline]
Cerone, M.A., Londono-Vallejo, J.A., and Bacchetti, S. 2001. Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum. Mol. Genet. 10: 1945-1952.
Cesare, A.J. and Griffith, J.D. 2004. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol. Cell. Biol. 24: 9948-9957.
Chang, S., Khoo, C., Naylor, M., Maser, R., and DePinho, R.A. 2003. Telomere-based crisis: Functional differences between telomerase activation and ALT in tumor progression. Genes & Dev. 17: 88-100.
Chang, C-C., Kuo, I.C., Ling, I.F., Chen, C.T., Chen, H.C., Lou, P.J., Lin, J.J., and Chang T.A. 2004. Detection of quadruplex DNA structures in human telomeres by a fluorescent carbazole derivative. Anal. Chem. 76: 4490-4494.[Medline]
Chang, S., Multani, A.S., Cabrera, N.G., Naylor, M.L., Laud, P., Lombard, D., Pathak, S., Guarente, L., and DePinho, R.A. 2004. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat. Genet. 36: 877-882.[CrossRef][Medline]
Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11: 1921-1929.[Medline]
Crabbe, L., Verdun, R.E., Haggblom, C.I., and Karlseder, J. 2004. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306: 1951-1953.
Du, X., Shen, J., Kugan, N., Furth, E., Lombard, D., Cheung, C., Pak, S., Luo, G., Pignolo, R., DePinho, R.A., et al. 2004. Telomere shortening exposes functions for the Werner and Bloom syndrome genes in mice. Mol. Cell. Biol. 24: 8437-8446.
Dunham, M.A., Neumann, A.A., Fasching C.L., and Reddel, R.R. 2000. Telomere maintenance by recombination in human cells. Nat. Genet. 26: 447-450.[CrossRef][Medline]
Faragher, R.G., Kill, I.R., Hunter, J.A., Pope, F.M., Tannock, C., and Shall, S. 1993. The gene responsible for Werner syndrome may be a cell division `counting' gene. Proc. Natl. Acad. Sci. 90: 12030-12034.
Granotier, C., Pennarun, G., Riou, L., Hoffschir, F., Gauthier, L.R., De Cian, A., Gomez, D., Mandine, E., Riou, J.F., Mergny, J.-L., et al. 2005. Preferential binding of a G-quadruplex ligand to human chromosome ends. Nucleic Acids Res. 33: 4182-4190.
Gray, M.D., Shen, J.C., Kamath-Loeb, A.S., Blank, A., Sopher, B.L., Martin, G.M., Oshima, J., and Loeb, L.A. 1997. The Werner syndrome protein is a DNA helicase. Nat. Genet. 17: 100-103.[CrossRef][Medline]
Hemann, M.T., Strong, M.A., Hao, L.Y., and Greider, C.W. 2001. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107: 67-77.[CrossRef][Medline]
Hickson, I. D. 2003. RecQ helicases: Caretakers of the genome. Nat. Rev. Cancer 3: 169-178.[CrossRef][Medline]
Huang, S., Li, B., Gray, M.D., Oshima, J., Mian, S.I., and Campisi, J. 1998. The premature ageing syndrome protein, WRN, is a 3'
5' exonuclease. Nat. Genet. 20: 114-116.[CrossRef][Medline]
Johnson, F.B., Marciniak, R.A., McVey, M., Stewart, S.A., Hahn, C.W., and Guarente, L. 2001. The Saccharomyces cerevisiae WRN homolog Sgs1 participates in telomere maintenance in cells lacking telomerase. EMBO J. 20: 905-913.[CrossRef][Medline]
Kamijo, T., Zindy, F., Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., Grosveld, G., and Sherr, C.J. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659.[CrossRef][Medline]
Liu, G., Parant, J.M., Lang, G., Chau, P., Chavez-Reyes, A., El-Naggar, A.K., Multani, A., Chang, S., and Lozano, G. 2004. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat. Genet. 36: 63-68.[CrossRef][Medline]
Lombard, D.B., Beard, C., Johnson, B., Marciniak, R.A., Dausman, J., Bronson, R., Buhlmann, J.E., Lipman R., Curry, R., Sharpe, A., et al. 2000. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol. Cell. Biol. 20: 3286-3291.
Londono-Vallejo, J.A., Der-Sarkissian, H., Cazes, L., Bacchetti, S., and Reddel, R.R. 2004. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res. 64: 2324-2327.
Lu, X., Lozano, G., and Donehower, L.A. 2003. Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system. Mutat. Res. 522: 69-83.[Medline]
Martin, G.M. and Oshima, J. 2000. Lessons from human progeroid syndromes. Nature 408: 263-266.[CrossRef][Medline]
Maser, R.S. and DePinho, R.A. 2002. Connecting chromosomes, crisis, and cancer. Science 297: 565-569.
Mekeel, K.L., Tang, W., Kachnic, L.A., Luo, C.M., DeFrank, J.S., and Powell, S.N. 1997. Inactivation of p53 results in high rates of homologous recombination. Oncogene 14: 1847-1857.[CrossRef][Medline]
Melcher, R., von Golitschek., R., Steinlein, C., Schindler, D., Neitzel, H., Kainer, K., Schmid, M., and Hoehn, H. 2000. Spectral karyotyping of Werner syndrome fibroblast cultures. Cytogenet. Cell Genet. 91: 180-185.[CrossRef][Medline]
Mohaghegh, P., Karow, J.K., Brosh Jr., R.M., Bohr, V.A. and Hickson, I. D. 2001. The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res. 29: 2843-2849.
Myung, K., Datta, A., Chen, C., and Kolodner, R.D. 2001. SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination. Nat. Genet. 27: 113-116.[CrossRef][Medline]
Opresko, P.L., Otterlei, M., Graakjaer, J., Bruheim, P., Dawut, L., Kolvraa, S., May, A., Seidman, M.M., and Bohr V.A. 2004. The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol. Cell. 14: 763-774.[CrossRef][Medline]
Opresko, P.L., Mason, P.A., Podell, E.R., Lei, M., Hickson, I.D., Cech, T.R., and Bohr, V.A. 2005. POT1 stimulates recQ helicases WRN and BLM to unwind telomeric DNA substrates. J. Biol. Chem. 280: 32069-32080. [Epub July 18, 2005.]
Perrem, K., Colgin, L.M., Neumann, A.A., Yeager, T.R., and Reddel, R.R. 2001. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21: 3862-3875.
Prince, P.R., Emond, M.J., and Monnat Jr., R.J. 2001. Loss of Werner syndrome protein function promotes aberrant mitotic recombination. Genes & Dev. 15: 933-938.
Quelle, D.E., Ashmun, R.A., Hannon, G.J., Rehberger, P.A., Trono, D., Richter, K.H., Walker, C., Beach, D., Sherr, C.J., and Serrano, M. 1995. Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene 11: 635-645.[Medline]
Razak, Z.R., Varkonyi, R.J., Kulp-McEliece, M., Caslini, C., Testa, J.R., Murphy, M.E., and Broccoli, D. 2004. p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance. Mol. Cell. Biol. 24: 5967-5977.
Romanov, S.R., Kozakiewicz, B.K., Holst, C.R., Stampfer, M.R., Haupt, L.M., and Tlsty, T.D. 2001. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409: 633-637.[CrossRef][Medline]
Salk, D., Au, K., Hoehn, H., and Martin, G.M. 1981. Cytogenetics of Werner's syndrome cultured skin fibroblasts: Variegated translocation mosaicism. Cytogenet. Cell Genet. 30: 92-107.[Medline]
Schaffitzel, C., Berger, I., Postberg, J. Hanes, J., Lipps, H.J., and Plückthun, A. 2001. In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc. Natl. Acad. Sci. 98: 8572-8577.
Smogorzewska, A. and de Lange, T. 2004. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73: 177-208.[CrossRef][Medline]
Stansel, R.M., Subramanian, D., and Griffith, J.D. 2002. p53 binds telomeric single strand overhangs and t-loop junctions in vitro. J. Biol. Chem. 277: 11625-11628.
Tarsounas, M., Muñoz, P., Claas, A., Smiraldo, P.G., Pittman, D. L., Blasco, M.A., and West, S.C. 2004. Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117: 337-347.[CrossRef][Medline]
Wang, R.C., Smogorzewska, A., and de Lange, T. 2004. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119: 355-368.[CrossRef][Medline]
Wyllie, F.S., Jones, C.J., Skinner, J.W., Haughton, M.F., Wallis, C., Wynford-Thomas, D., Faragher, R.G., and Kipling, D. 2000. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24: 16-17.[CrossRef][Medline]
Yamagata, K., Kato, J., Shimamoto, A., Goto, M., Furuichi, Y., and Ikeda, H. 1998. Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: Implication for genomic instability in human diseases. Proc. Natl. Acad. Sci. 95: 8733-8738.
Yeager, T.R., Neumann, A.A., Englezou, A., Huschtscha, L.I., Noble, J.R., and Reddel, R.R. 1999. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59: 4175-4179.
Zaug, A.J., Podell, E.R., and Cech, T.R. 2005. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc. Natl. Acad. Sci. 102: 10864-10869. [Epub July 25, 2005.]
Zhu, X.D., Niedernhofer, L., Kuster, B., Mann, M., Hoeijmakers, J.H., and de Lange, T. 2003. ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell 12: 1489-1498.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W.-H. Cheng, D. Muftic, M. Muftuoglu, L. Dawut, C. Morris, T. Helleday, Y. Shiloh, and V. A. Bohr WRN Is Required for ATM Activation and the S-Phase Checkpoint in Response to Interstrand Cross-Link-Induced DNA Double-Strand Breaks Mol. Biol. Cell, September 1, 2008; 19(9): 3923 - 3933. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sowd, M. Lei, and P. L. Opresko Mechanism and substrate specificity of telomeric protein POT1 stimulation of the Werner syndrome helicase Nucleic Acids Res., August 1, 2008; 36(13): 4242 - 4256. |